Drug & intervention
eltrombopag 25 MG Powder for Oral Suspension [Promacta]
RxCUI 1859501
What this record represents
SBD · RxNormThis is an RxNorm SBD drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
PromactaBN · CureCurrent ID 40341
eltrombopag 25 MG [Promacta]SBDC · CureCurrent ID 40342
eltrombopag 50 MG [Promacta]SBDC · CureCurrent ID 40347
eltrombopag 75 MG [Promacta]SBDC · CureCurrent ID 43720
eltrombopag 12.5 MG [Promacta]SBDC · CureCurrent ID 51974
eltrombopag Oral Tablet [Promacta]SBDF · CureCurrent ID 40343
eltrombopag 25 MG Oral Tablet [Promacta]SBD · CureCurrent ID 40344
eltrombopag 50 MG Oral Tablet [Promacta]SBD · CureCurrent ID 40348
eltrombopag 75 MG Oral Tablet [Promacta]SBD · CureCurrent ID 43721
eltrombopag 12.5 MG Oral Tablet [Promacta]SBD · CureCurrent ID 51975
eltrombopag Powder for Oral Suspension [Promacta]SBDF · CureCurrent ID 64541
eltrombopag 12.5 MG Powder for Oral Suspension [Promacta]SBD · CureCurrent ID 67891
Molecular structure
Active ingredient: eltrombopagAdvertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.